FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:2253-2254 May 26, 2005 Number 21

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by Stephen Waxman. 513 pp., illustrated. San Diego, Calif., Elsevier Academic Press, 2005. $125. ISBN 0-12-738903-2.

Stephen Waxman is the epitome of a molecular scientist who heads a clinical department. His research interests focus on membrane channels in health and disease, especially in spinal cord injury and multiple sclerosis. Waxman deplores the bad old days (i.e., as recently as the 1950s), when the inimitable Labe Scheinberg said the best we could do for multiple sclerosis was "diagnose and adios." Richard Masland, a former director of the National Institute of Neurological Disorders and Stroke, said something like "for all the good we do for multiple sclerosis, neurologists could be replaced by sympathetic nuns."

(Figure)

View larger version (89K): [in this window] [in a new window]   Pyramidal . . . [Full Text of this Article]

 

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.